直击隐蔽乱象！检察机关督促整治电商平台诊所变相销售网络禁售药品

Core Viewpoint - The article highlights the illegal sale of banned drugs through e-commerce platforms, emphasizing the need for regulatory oversight to ensure public safety in medication use [1][2] Group 1: Regulatory Actions - The Beijing Railway Transportation Procuratorate identified illegal activities on the e-commerce platform "Bianmin Zhaoyao," where clinics were selling banned drugs without proper medical assessments [1] - Following media exposure in April 2024, the procuratorate initiated an investigation in October, utilizing big data legal supervision models to gather evidence [2] - A public hearing clarified the legal relationship between clinics and users as "sales" rather than "medical treatment," necessitating oversight from market supervision authorities [2] Group 2: Enforcement and Compliance - Joint inspections by market supervision and health departments led to significant actions, including the inspection of 161 medical institutions and online drug sales companies, with 21 drug-related cases being addressed [2] - The procuratorate facilitated the signing of a memorandum to enhance collaboration between administrative agencies for better enforcement against the illegal sale of banned drugs [2] - Measures were implemented to improve the vetting of merchants on e-commerce platforms and to increase transaction risk warnings to prevent illegal activities [2]